Neoadjuvant Immunotherapy in High-risk Stage II and Stage III Melanoma

Faculty(s)

• 

  Alexander C.J van Akkooi, MD, PhD, MSc, FRACS (he/him/his)

  Surgical Oncologist
  Melanoma Institute of Australia
  Sydney, New South Wales, Australia

  Slides